NCT06461182View on ClinicalTrials.gov

Ga-68-CXCR4 PET/CT in Indolent B-cell Lymphoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 29, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2027

Conditions
Indolent B-Cell Non-Hodgkin Lymphoma
Interventions
DRUG

Ga-68-CXCR4

Ga-68-CXCR4 for PET/CT procedure in Indolent B-cell Lymphoma

Trial Locations (1)

1125019

RECRUITING

Koo Foundation Sun Yat-Sen Cancer Center, Taipei

All Listed Sponsors
lead

Koo Foundation Sun Yat-Sen Cancer Center

OTHER